Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion
Thomas Blevins, Johanna Ulloa, Mehrbod Vakhshoori, Kevin B. Kaiserman et al.
Citations
5 citations
Journal
Diabetes Therapy
Topics
Diabetes Management and Research
Field-Weighted Citation Impact (FWCI)
6.47
article
Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion
Thomas Blevins, Johanna Ulloa, Mehrbod Vakhshoori, Kevin B. Kaiserman, Christopher Jacobson, Kevin Codorniz, Joanne Rinker, Pamela Lobo Moreno, Jennifer Pleitez, Joseph Sylvan, Scott Lee
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
Diabetes TherapyVol. 16(8)
Institutions
Loma Linda University Medical Center (US), Loma Linda University (US), MannKind Corporation (United States) (US), Texas Diabetes & Endocrinology (US)